The aim is to explore nanocatalytic approaches for regulating age-related diseases.
Developed nanocatalytic interventions targeting key molecular pathways.
Evaluated the efficacy of nanocatalysts in preclinical models.
Utilized advanced biomarkers for assessing disease progression.
Demonstrated significant reductions in markers of age-related diseases.
Enhancements in cellular function and longevity observed in treated models.
Provided evidence of improved efficacy compared to traditional approaches.
Abstract
With the accelerating ageing of the global population, there is an urgent need to develop effective strategies for the management of age-related diseases. Despite the development and clinical application of...